We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

8 hedge funds and large institutions have $1.26M invested in Intelligent Bio Solutions in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,074% more capital invested

Capital invested by funds: $108K → $1.26M (+$1.16M)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

1.12% more ownership

Funds ownership: 0.18%1.29% (+1.1%)

0% more funds holding

Funds holding: 88 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$884K +$1.15M +61,389 New
ACM
2
Altium Capital Management
New York
$215K +$278K +14,925 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$70.6K +$41.8K +2,241 +84%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$51.1K +$66.2K +3,549 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$22.3K
Goldman Sachs
6
Goldman Sachs
New York
$18.5K +$23.9K +1,282 New
UBS Group
7
UBS Group
Switzerland
$1.69K -$3.23K -173 -60%
Bank of America
8
Bank of America
North Carolina
$65 +$19 +1 +25%
SS
9
SBI Securities
Japan
$1 -$373 -20 Closed
TSS
10
Two Sigma Securities
New York
-$21.6K -1,540 Closed
GSC
11
Ground Swell Capital
South Carolina
-$14.6K -1,040 Closed
TRCT
12
Tower Research Capital (TRC)
New York
-$8.12K -580 Closed

INBS Hedge Fund Activity: Q1 2025 in Review

8 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2025, worth a combined $1.26M — up 1,074% from $108K a quarter earlier.

Fund positioning in INBS was balanced in Q1 2025: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $1.15M. The largest seller was Two Sigma Securities, exiting entirely with an estimated $21.6K sold.

  • 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $1.26M of Intelligent Bio Solutions stock for Q1 2025, up 1,074% quarter-over-quarter.
  • 4 funds opened new Intelligent Bio Solutions positions in Q1 2025 and 4 closed out, a net change of 0 holders.
  • The largest Intelligent Bio Solutions buyer in Q1 2025 was Alyeska Investment Group, an estimated $1.15M added.
  • The largest Intelligent Bio Solutions seller in Q1 2025 was Two Sigma Securities, an estimated $21.6K sold.

Based on aggregated 13F filings for Q1 2025.